Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1141.3000 -6.40 (-0.56%)
NSE Jul 09, 2025 13:28 PM
Volume: 741.9K
 

1141.30
-0.56%
Angel Broking
Aurobindo Pharmaceuticals (APL) has a big relief in form of Establishment Inspection report (EIR) for Unit-4 facility in which the USFDA has closed issued Form 483. The Form 483 is issued to a firms management at the conclusion of an inspection when an investigator(s) has observed any conditions that may constitute violations of the Food
Aurobindo Pharma Ltd.'s price crossed below 50Day SMA today
More from Aurobindo Pharma Ltd.
Recommended